By J. Jala | 07:23 PM April 26, 2021
Health officials are still investigating a reported frontliner in Bohol who had reportedly suffered serious adverse events after receiving the second dose of the Sinovac Covid-19 vaccine.
According to Dr. Mary Jean Loreche, the spokesperson and chief pathologist of Department of Health Region 7 (DOH-7), in her media briefing this afternoon, the report would still determine the circumstances and establish the facts about it.
The information they just released earlier today is that the individual is a frontliner and is under the age of 35 years.
The said frontliner has a history of being hypertensive.
Loreche added that their surveillance officers are still tracking the entire story and among other things they will check the hospital records, as well.
In her Central Visayas COVID-19 Vaccination report on Monday noon time, Loreche first announced that there were 181 mild adverse events reported for those who received the second dose of Sinovac and one (1) serious event recorded.
There was also a recorded one person who suffered serious adverse events and 1,067 mild adverse events after they were administered with the first dose.
There were 1,316 mild adverse events among those given the first dose of the AstraZeneca vaccine.
In total, there were 2,567 recorded to have experienced adverse events in Central Visayas since from the first day of the vaccination rollout on March 4 up to April 25, 2021.